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Abstract 
Our study aims at examining the suitability of Scopus for bibliometric analyses in comparison with the Web of Science 
(WOS). In particular we want to explore if the outcome of bibliometric analyses differs between Scopus and WOS and, 
if yes, in which aspects. In doing so we focus on the following questions: To which extent are high impact JCR (Journal 
Citation Reports) journals covered by Scopus? Are the impact factor and the immediacy index usually lower for a JCR 
journal than the corresponding indicators computed in Scopus? Are there high impact journals not covered by the 
JCR? And, finally, how reliable are the data in these two databases? 
Since journal indicators like the impact factor and the immediacy index differ among disciplines, we analysed only 
journals from the subject pharmacy and pharmaceutical sciences. Focussing on one subject category offers 
furthermore the possibility to go into more detail when comparing the databases. 
The findings of our study can be summarized as follows: 
• Each top-100 JCR pharmacy journal was covered by Scopus.  
• The impact factor was higher for 82 and the immediacy index greater for 78 journals in Scopus in 
2005. Pharmacy journals with a high impact factor in the JCR usually have a high impact factor in 
Scopus.  
• Several high but no top-impact journal could be identified in Scopus which were not reported in 
JCR. 
• The two databases differed in the number of articles within a tolerable margin of deviation for 
most journals. 
Keywords: bibliometric analysis; Scopus; Web of Science; Journal Citation Reports; impact factor; immediacy 
index; comparison of databases; data reliability 
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1. Introduction 
In 2002, David Adam [1] reported in his article in Nature that the Institute for Scientific Information (ISI) was 
the undisputed king of the counting houses and the indispensable instrument for scientometric purposes and 
especially for citation analysis. Adam also foresaw that new software scanning articles, extracting references and 
automatically generating citation indices may challenge ISI’s monopoly shortly after. Late in November 2004 
Scopus, a research tool from Elsevier Publishing Company, was commercially launched and claimed to be the 
"world's largest abstract and indexing database" [2].  
The Scopus Web site [3] provides detailed information about the database which has enlisted the 
collaboration of over 300 researchers world-wide at 21 different institutions for extensive product testing and 
feedback. In the last two years the product has improved constantly. Scopus has emerged as a dependable research 
tool providing a user friendly search interface. Furthermore, and even more important, Scopus offers reliable and 
easy to use citation searching, a feature that until recently has been the exclusive domain of ISI. Actually its new 
citation tracker has been emulated by its competitor, the Web of Science (WOS), which illustrates the importance 
and impact this product has gained by now. 
There are already several publications which provide more or less extensive evaluations of Scopus with 
particular emphasis on a comparison with the Web of Science (e. g. Deis & Goodman [4-5], Gorraiz [6]; Jacso [7], 
LaGuardia [8], Pipp [9], Schneider [10], Wildner [11]). Just recently, a comprehensive study has been conducted 
at Utrecht University Library comparing Scopus, Web of Science and Google Scholar with regards to coverage 
and functionality [12]. However there are only a few studies which focused on the suitability of these citation 
databases for scientometric analyses.  
In their study which analysed citation counts of the Journal of the American Society for Information Science 
and Technology (JASIST), Bauer and Bakkalbasi [13] found that the Web of Science provided more citation 
counts to 1985 articles, although this could not be tested statistically. For JASIST articles published in 2000, there 
was no significant difference between Web of Science and Scopus. Similar results are reported by Jacso [14]. In a 
recent publication, Ball and Tunger [15] compare the two databases with regard to the number of articles covered, 
the areas of interest, the number of non-cited articles, and the number of citations of a set of articles. The authors 
conclude that the outcome of bibliometric analyses may be quite different depending on the database chosen. The 
identification of such differences was also at the core of the article by Klavans and Boyack [16] who investigated 
if Scopus and Web of Science generate maps representing the structure of science that are structurally equivalent. 
2. Research questions and methodology 
As already mentioned above, Scopus has emerged as a reliable and easy to use research tool for citation 
searching. However when it comes up to bibliometric analyses, it seems that Scopus did not yet break the 
monopoly of its competitor. For this reason, our study aims at examining the suitability of Scopus for bibliometric 
analyses in comparison with the Web of Science. In particular we want to investigate Scopus and the Web of 
Science with regard to the following issues: 
1. To which extent are high impact JCR (Journal Citation Reports) journals covered by Scopus? Are there 
journals with a high impact factor which are not included in Scopus? 
2. Are the impact factor and the immediacy index usually lower for a JCR journal than the corresponding 
indicators computed for that journal in the Scopus database? 
3. Are there high impact journals not considered by the JCR?  
4. How reliable are the data in these two databases? Do the numbers of research and review articles match 
up in Scopus and JCR? 
Since journal indicators like the impact factor and the immediacy index differ among disciplines, we 
investigated only journals from the subject pharmacy and pharmaceutical sciences. Focussing on one subject 
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category offers furthermore the possibility to go into more detail when comparing the databases. Though we 
analysed only pharma journals, our study has also broader implications. Besides revealing all problems involved 
when comparing two citation databases, it explores the appropriateness of Scopus for bibliometric analyses. 
Our original journal sample was derived from the JCR of the year 2005, subject category “pharmacology & 
pharmacy”. We downloaded the data (impact factor, immediacy index and number of articles published in the 
year 2005) for the top-100 journals ranked by impact factor and complemented these data with the number of 
2003 and 2004 articles (document types article and review) and the number of 2005 citations to 2003, 2004 and 
2005 articles. 
Since Scopus does not provide any citation statistics comparable to the JCR, we had to retrieve the necessary 
data from this database manually. But since Scopus has a sophisticated search interface, data collection could be 
performed with relatively little efforts. When computing the impact factor [for a basic introduction please see 17] 
and the immediacy index for the Scopus journals, we used the same formulas as in the JCR. Attention has to be 
paid to the fact that the impact factor (and the immediacy index) only considers research and review articles. As a 
consequence, we limited our search statements to these document types. In order to determine if there are high 
impact pharma journals which are not included in the JCR, we used journal lists provided by Science Direct and 
Subito. 
All data were collected in November 2006. 
3. Findings  
The presentation of the results follows the research questions outlined above. 
3.1. Coverage of JCR high impact pharmacology and pharmacy journals in Scopus 
A comparison of journals from a certain subject category between the two databases is not without problems 
for various reasons. Usually different databases use different classification systems. While the relevant subject 
category is “pharmacology, toxicology and pharmaceutics” in Scopus, the Web of Science uses two categories 
(“pharmacology & pharmacy” and “toxicology”). Furthermore, the different size of the databases must be 
considered. While there were 193 journals included in the subject category “pharmacology & pharmacy” (and 75 
partly overlapping “toxicology” journals) in the JCR, Scopus covered altogether2 266 active titles. (This confirms 
previous studies [e.g. 2, 7, 12] according to which Scopus has a strong concentration on health and life sciences.) 
As a consequence, the coverage of JCR journals in Scopus is broader than contrariwise. It was not expected, 
however, that each of the top-100 JCR pharmacy journals (ranked by impact factor) was included in Scopus.  
Finally the indexing procedure is not consistent in different databases. 96 journals were indexed as pharma 
journals in both citation indices. The remaining four journals were assigned to other categories in Scopus 
(“medicine” and “biochemistry, genetics and molecular biology”). 
                                                          
2 I.e. also pharma journals in subcategories (e.g. “pharmacology (medical)”) of other classes (e.g.“medicine (all)”) were 
considered. 
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Table 1. Top 100 JCR (2005) journals (subject category “pharmacology & pharmacy”): impact factor and 
corresponding values computed in Scopus  
Rank Impact factor Rank Impact factor 
JCR Scopus 
Abbrev. journal title 
JCR Scopus Diff(%) JCR Scopus 
Abbrev. journal title 
JCR Scopus Diff(%) 
1 1 Annu Rev Pharmacol 19.833 20.813 4.9% 51 50 Brit J Clin Pharmaco 2.777 3.083 11.0% 
2 2 Nat Rev Drug Discov 18.775 17.886 5.0% 52 66 Behav Pharmacol 2.773 2.646 4.8% 
3 5 Rev Physiol Bioch P 17.053 9.824 73.6% 53 48 Prog Neuro-Psychoph 2.769 3.221 16.3% 
4 3 Pharmacol Rev 15.689 15.958 1.7% 54 52 Pharm Res 2.752 3.014 9.5% 
5 4 Trends Pharmacol Sci 10.372 10.507 1.3% 55 47 Int Clin Psychopharm 2.745 3.287 19.7% 
6 6 Pharmacol Therapeut 8.357 9.086 8.7% 56 49 Ther Drug Monit 2.718 3.105 14.2% 
7 7 Med Res Rev 7.964 8.636 8.4% 57 57 Pharmacopsychiatry 2.620 2.846 8.6% 
8 18 Drug Discov Today 7.755 5.418 43.1% 58 62 Toxicology 2.584 2.711 4.9% 
9 9 Clin Pharmacol Ther 7.526 7.772 3.3% 59 74 Neurotoxicology 2.576 2.528 1.9% 
10 8 Adv Drug Deliver Rev 7.189 8.144 13.3% 60 56 Eur J Pharm 2.525 2.876 13.9% 
11 10 Drug Resist Update 6.172 7.500 21.5% 61 73 Comb Chem High T 2.518 2.557 1.6% 
12 11 Pharmacogenetics 5.882 6.480 10.2% 62 58 Life Sci 2.512 2.806 11.7% 
13 15 Curr Drug Metab 5.416 5.805 7.2% 63 61 Eur J Pharmacol 2.477 2.733 10.3% 
14 17 Neuropsychopharmacol 5.369 5.518 2.8% 64 64 Expert Opin Ther Tar 2.458 2.657 8.1% 
15 13 Curr Opin Pharmacol 5.366 5.979 11.4% 65 63 Int J Antimicrob Ag 2.428 2.687 10.7% 
16 32 Antivir Ther 5.286 4.148 27.4% 66 100 AAPS Pharmsci 2.417 0.983 145.8% 
17 12 Clin Pharmacokinet 5.195 6.355 22.3% 67 67 Invest New Drug 2.417 2.646 9.5% 
18 36 Drug Metab Rev 5.153 3.905 32.0% 68 69 Eur J Pharm SCI 2.347 2.593 10.5% 
19 14 J Clin Psychopharm 5.145 5.812 13.0% 69 54 J Child Adol Psychop 2.307 2.925 26.8% 
20 21 Curr Med Chem 4.904 5.210 6.2% 70 70 Eur J Clin Pharmacol 2.298 2.578 12.2% 
21 20 Curr Pharm Design 4.829 5.297 9.7% 71 80 J Nat Prod 2.267 2.380 5.0% 
22 19 Mol Pharmacol 4.612 5.326 15.5% 72 86 Toxicon 2.255 2.272 0.7% 
23 16 Drugs 4.466 5.637 26.2% 73 85 Control Clin Trials 2.238 2.275 1.7% 
24 26 Curr Drug Targets 4.398 4.363 0.8% 74 68 J Pharm Sci-US 2.237 2.635 17.8% 
25 22 Antimicrob Agents Ch 4.379 5.008 14.4% 75 84 Cancer Chemoth 2.235 2.278 1.9% 
26 27 J Pharmacol Exp Ther 4.098 4.345 6.0% 76 81 Peptides 2.231 2.348 5.2% 
27 31 Drug Metab Dispos 4.015 4.157 3.5% 77 65 Pharmacoeconomics 2.198 2.651 20.6% 
28 24 Psychopharmacology 3.994 4.438 11.1% 78 99 Drug News Perspect 2.159 1.677 28.7% 
29 34 Pharmacogenomics J 3.989 4.010 0.5% 79 77 Int J Pharm 2.156 2.461 14.1% 
30 42 Int J Neuropsychoph 3.981 3.570 11.5% 80 92 Cardiovasc Drug Rev 2.122 2.082 1.9% 
31 25 J Antimicrob Chemoth 3.886 4.402 13.3% 81 89 N-S Arch Pharmacol 2.098 2.178 3.8% 
32 33 Curr Opin Drug Disc 3.778 4.093 8.3% 82 71 Pharmacol Res 2.096 2.574 22.8% 
33 29 Crit Rev Ther Drug 3.696 4.280 15.8% 83 94 Chirality 2.072 2.018 2.7% 
34 30 J Control Release 3.696 4.217 14.1% 84 55 Drug Aging 2.072 2.923 41.1% 
35 28 CNS Drugs 3.671 4.318 17.6% 85 72 Microb Drug Resist 2.072 2.559 23.5% 
36 35 Neuropharmacology 3.637 3.958 8.8% 86 79 Biomed Pharmacother 2.069 2.386 15.3% 
37 59 Pharmacogenomics 3.623 2.794 29.7% 87 87 Assay Drug Dev 2.060 2.198 6.7% 
38 38 Biochem Pharmacol 3.617 3.829 5.9% 88 82 J Pharm Pharm Sci 2.042 2.324 13.8% 
39 60 Eur Neuropsychopharm 3.510 2.760 27.2% 89 88 Int Immunopharmacol 2.008 2.183 8.7% 
40 23 Aliment Pharm Therap 3.434 4.891 42.4% 90 91 Pharmacol Biochem 1.970 2.102 6.7% 
41 40 Int J Immunopath Ph 3.418 3.769 10.3% 91 90 Chem-Biol Interact 1.968 2.141 8.8% 
42 43 Brit J Pharmacol 3.410 3.546 4.0% 92 97 Exp Clin 1.952 1.882 3.7% 
43 41 Antivir Res 3.406 3.703 8.7% 93 75 Pharmacotherapy 1.920 2.486 29.5% 
44 53 CNS Drug Rev 3.353 2.953 13.5% 94 96 Anti-Cancer Drug 1.907 1.977 3.6% 
45 45 Expert Opin Inv Drug 3.267 3.479 6.5% 95 76 Clin Neuropharmacol 1.890 2.466 30.5% 
46 37 Drug Safety 3.211 3.885 21.0% 96 93 Hum Psychopharm 1.890 2.025 7.2% 
47 51 J Psychopharmacol 3.178 3.037 4.6% 97 95 J Pharmaceut Biomed 1.889 1.984 5.0% 
48 46 Toxicol Appl Pharm 3.148 3.340 6.1% 98 78 Ann Pharmacother 1.837 2.420 31.8% 
49 39 Clin Ther 3.030 3.776 24.6% 99 98 Qsar Comb Sci 1.826 1.850 1.3% 
50 44 J Clin Pharmacol 2.889 3.514 21.6% 100 83 Expert Opin 1.823 2.300 26.2% 
Italics: higher values in JCR; bold: impact factor differs more than 10% 
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3.2. Differences in impact factor and immediacy index 
Since there are more journals included in Scopus than in WOS, a journal in Scopus has a higher chance to get 
cited in general. Therefore the values for the impact factor and the immediacy index should also be higher in 
Scopus. This assumption turned out to be true for most journals in our journal sample. The impact factor was 
higher for 82 journals in Scopus, 18 journals had a higher impact factor in the JCR. Similarly the immediacy index 
of 78 journals had higher values in Scopus. As can be seen in Table 1, a journal with a high impact factor in the 
JCR usually has a high impact factor in Scopus, and vice versa. This goes along with the correlation (Pearson’s 
r=0.96) of the impact factors of the top-100 pharma journals in the JCR and those computed for them in Scopus.  
The size of the differences (in %) between the impact factor values follows a skewed distribution (see Table 
2). For most journals, the difference is relatively small (median = 10.3%). Yet two journals (“Reviews of 
Physiology Biochemistry and Pharmacology” and “AAPS Pharmsci”) attracted our attention because of their 
remarkable discrepancies of 74 and 146 percent. A first analysis shows that these big differences are not only 
caused by different citation frequencies but also by high deviations in the numbers of articles. In order to identify 
the reasons for these differences, we will go into deeper analysis in the following sub-section (reliability of data). 
 
Table 2. Distribution of the % differences between Scopus and JCR in the impact factor, immediacy index, number 
of articles in 2003, 2004 and 2005, and the number of 2005 citations to articles from those years (basis for 
comparison: top-100 JCR pharma journals ranked by impact factor)  
2005 citations to   Impact 
factor 
2003 
articles 
2004 
articles 03’art. 04’art. 05’art. 
2005 
articles 
Immediacy
index 
        Differences between 
Scopus and JCR         
 0-5% 25 71 68 21 15 6 66 7 
 5-10% 23 10 11 28 20 7 10 8 
 10-20% 28 7 11 32 35 20 10 24 
 20-30% 16 7 5 13 18 25 2 25 
 30-50% 6 2 2 5 11 24 5 19 
 >=50% 2 3 3 1 1 16 4 14 
 Total 100 100 100 100 100 98 97 97 
          
Median (of % differences) 10.3% 2.1% 2.1% 10.5% 14.4% 24.5% 1.6% 23.4% 
No. of journals with 
greater values in Scopus  
 
82 
 
65 
 
65 
 
86 
 
94 
 
86 
 
66 
 
78 
No. of journals with 
greater values in JCR 
 
18 
 
14 
 
17 
 
13 
 
6 
 
10 
 
11 
 
18 
 
 
Table 2 also confirms the original assumption that higher citations in Scopus, which are generated by more 
(pharma) journals in this database, are the main cause for the higher impact factor values. The median of the 
percentage differences between Scopus and the JCR in the impact factor (10.3 %) is similar to those in the 2005 
citations to articles published in 2003 (10.5 %) and 2004 (14.4 %). (Hence, it would be worth considering to 
normalize the impact factor values in order to allow a “fair” comparison.)  
The higher differences in the immediacy index (median = 23.4 %) are also mainly due to greater deviations in 
the number of citations which articles published in 2005 have received in the same year (median = 24.5 %). 
However, it must be taken into account that, because the number of citations in the year in which these articles 
were published is low in general, already small deviations in the absolute numbers can show high percentage 
effects. As was pointed out by one of the referees, “Molecular Pharmacology” is an extreme example. The reason 
 
 
Journal of Information Science, XX (X) 2007, pp. 1–11 © CILIP, DOI: 10.1177/0165551506nnnnnn 5
JIS-0584 - v3 Received: 2nd July 2007 Revised: 31st October 2007
 Accepted for Publication
By the Journal of Information Science: http://jis.sagepub.co.uk 
 
Gorraiz and Schloegl 
for the huge difference in the immediacy index for this journal (nearly 8800% - see Table 3) is due to an error in 
the JCR. While a search in WOS showed 413 citations in the year 2005 to articles published in the same year, the 
JCR lists only 6 citations. As a consequence, the immediacy index ought to be corrected to 0.93 in the JCR 
resulting in a much smaller difference in comparison with the corresponding value computed in Scopus. 
 
Table 3. Top 50 JCR (2005) journals (subject category “pharmacology & pharmacy”) ranked by impact factor: 
immediacy index and corresponding values computed in Scopus  
Immediacy index Rank Immediacy index Rank
JCR Abbrev. journal title JCR Scopus Diff(%) JCR 
Abbrev. journal title 
JCR Scopus Diff(%) 
1 Annu Rev Pharmacol 5.793 7.172 23.8% 26 J Pharmacol Exp Ther 0.891 1.072 20.3% 
2 Nat Rev Drug Discov 3.364 2.574 30.7% 27 Drug Metab Dispos 0.733 0.787 7.4% 
3 Rev Physiol Bioch P 0.214 0.600 180.4% 28 Psychopharmacology 0.4 0.768 92.0% 
4 Pharmacol Rev 1.586 1.724 8.7% 29 Pharmacogenomics J 1.136 1.277 12.4% 
5 Trends Pharmacol Sci 1.951 2.054 5.3% 30 Int J Neuropsychoph 0.912 1.103 21.0% 
6 Pharmacol Therapeut 1 1.193 19.3% 31 J Antimicrob Chemoth 0.749 0.888 18.5% 
7 Med Res Rev 1.552 1.862 20.0% 32 Curr Opin Drug Disc 0.662 0.848 28.2% 
8 Drug Discov Today 1.125 1.287 14.4% 33 Crit Rev Ther Drug 0.333 0.545 63.8% 
9 Clin Pharmacol Ther 1.689 1.243 35.9% 34 J Control Release 0.429 0.479 11.7% 
10 Adv Drug Deliver Rev 1.176 1.520 29.3% 35 CNS Drugs 0.736 1.000 35.9% 
11 Drug Resist Update 0.227 0.556 144.7% 36 Neuropharmacology 0.552 0.692 25.4% 
12 Pharmacogenetics - - - 37 Pharmacogenomics 0.444 0.380 16.9% 
13 Curr Drug Metab 0.425 0.500 17.6% 38 Biochem Pharmacol 0.489 0.556 13.7% 
14 Neuropsychopharmac 1.181 1.421 20.3% 39 Eur Neuropsychopharm 1.215 1.488 22.5% 
15 Curr Opin Pharmacol 0.854 1.178 37.9% 40 Aliment Pharm Therap 0.578 0.732 26.6% 
16 Antivir Ther 0.642 0.626 2.6% 41 Int J Immunopath Ph 0.341 0.358 5.0% 
17 Clin Pharmacokinet 0.723 1.096 51.6% 42 Brit J Pharmacol 0.541 0.646 19.5% 
18 Drug Metab Rev 0.55 0.476 15.5% 43 Antivir Res 0.473 0.627 32.5% 
19 J Clin Psychopharm 0.824 1.022 24.0% 44 CNS Drug Rev 0.235 0.222 5.8% 
20 Curr Med Chem 0.542 0.605 11.5% 45 Expert Opin Inv Drug 0.354 0.504 42.3% 
21 Curr Pharm Design 1.194 1.418 18.7% 46 Drug Safety 0.646 0.938 45.2% 
22 Mol Pharmacol 0.014 1.245 8796% 47 J Psychopharmacol 0.434 0.500 15.2% 
23 Drugs 0.677 0.952 40.6% 48 Toxicol Appl Pharm 0.506 0.487 3.9% 
24 Curr Drug Targets 0.305 0.463 51.9% 49 Clin Ther 0.241 0.325 35.0% 
25 Antimicrob Agents Ch 0.82 0.984 20.0% 50 J Clin Pharmacol 0.578 0.711 23.1% 
Italics: higher values in JCR; bold: immediacy index differs more than 30% 
  
 
3.3. Reliability of data 
Contrary to the citations received, there should be only small differences in the number of articles between the 
two databases. Since Pipp [9, p. 13] reported differences in the provision of document types between the two 
databases which may strongly affect the number of retrieved records, we considered only articles and review 
articles. As can be seen in Table 2, the values for the median of the percentage differences are between 1.6 and 
2.1% in the three years. The difference in the number of research and review articles is below 5% for two thirds of 
all journals in each year. Nevertheless, we computed a wider difference of at least 10 percent for one fifth of all 
journals. There were even a few journals in each year, in which the article counts differed more than 50% (2003: 
“Reviews of Physiology Biochemistry and Pharmacology“, “Pharmacogenomics”, “Drug Discovery Today”, 
2004: “Reviews of Physiology, Biochemistry and Pharmacology“, “Drug News & Perspectives”, “AAPS 
Pharmsci”, 2005: “Nature Reviews Drug Discovery”, “CNS Drug Reviews”, “European Journal of 
Pharmaceutical Sciences”, “Drug News & Perspectives”). This raises severe questions with regard to data quality. 
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Table 4: “Reviews of Physiology, Biochemistry and Pharmacology”: number of review articles according to 
journal, JCR, WOS, and Scopus 
 2003 2004 2005 
No. of articles (data collected    
from journal volumes) 20 14 10 
No. of articles indexed in    
   JCR 8 11 14 
   Web of Science 8 11 21 
   Scopus 20 14 10 
 
In the following, we go into more details about the discrepancies of the two journals identified in the previous 
section. As is revealed by Table 4, the article counts in Scopus are accordant with the real values we collected for 
“Reviews of Physiology, Biochemistry and Pharmacology”. However, there are big deviations in the article 
numbers for this hybrid serial in comparison with the Web of Science. The main reason for this mismatch might 
be the irregular publication of this serial. Accordingly, a few volumes were not indexed in the proper publication 
year in WOS. As can also be seen in Table 4, there are again data inconsistencies between JCR and WOS for the 
year 2005. 
 
Table 5: “AAPS Pharmsci” and “AAPS Journal”: number of articles and review articles according to journal 
homepage, JCR, WOS, and Scopus 
 2003 2004 2005 
 AAPS PharmSCI AAPS  PharmSCI AAPS J AAPS J 
No. of articles (data collected     
from journal homepage) 32 14 19 83 
No. of articles indexed in     
   JCR 22 14 20 83 
   Web of Science 31 14 20 83 
   Scopus 33 19 18 76 (1) 
 
For the electronic journal “AAPS PharmSCI” (see Table 5) the JCR article data of the year 2003, which are 
used for the calculation of the impact factor, are again erroneous (22 instead of 32 articles) and not consistent with 
the WOS figures (31 articles). However, the indexing in JCR and WOS is nearly correct in the following years. 
Contrary to WOS, the title change (from “AAPS PharmSCI” to “AAPS J”) affected Scopus more negatively. In 
particular it is not very clear which articles refer to which journal title. For instance, a search for the former title 
(“AAPS PharmSCI”) in 2005 shows 76 articles and review articles assigned to “AAPS J”. However, a search for 
“AAPS J” in the same year lists only one article for this title (but 48 items for “AAPS Journal Electronic 
Resource”). 
For most other journals, the mismatch in the article counts was due to the different assignment to document 
types. For instance, various conference papers in “Drug Discovery Today”, “Drug News & Perspectives” and 
“CNS Drug Reviews” were categorized as articles in Scopus; in WOS they were nonexistent. For two other 
journals (“Nature Reviews Drug Discovery” and “Pharmacogenomics”) opinion papers were attributed to articles 
in Scopus but to editorial comments in WOS. And in the “European Journal of Pharmaceutical Sciences” meeting 
abstracts were wrongly assigned to articles in Scopus. As this short analysis reveals, both Scopus and WOS have 
problems with regard to the accuracy of data. Unlike Deis and Goodman [4, 5], our analysis suggests that Scopus 
is not worse than the Web of Science with regard to the completeness of (research and review) articles in journals. 
It must be considered, however, that our analysis was based on a small, more specialized and more present journal 
sample. 
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3.4. Pharmaceutical journals covered by Scopus but not included in the JCR 
In order to identify other high impact pharmaceutical journals not covered by the JCR, it would be easiest to 
compare the highest impact journals in Scopus with their counterparts in JCR. Though Scopus offers sophisticated 
tools for citation analysis, there are no citation statistics and rankings comparable with the JCR in this database as 
of now. As a consequence, the compilation of the high impact journals in this database can be rather laborious and 
time-consuming. For this reason we contacted Elsevier which provided us with the citation counts and number of 
articles for journals from the subject category “pharmacology, toxicology and pharmaceutical science” in Science 
Direct. After having checked the reliability of data for these 81 journals in Scopus (in case of data inconsistencies 
we used the Scopus data), we calculated the impact factor and the immediacy index and compared them with the 
results in JCR. 
 
Table 6. Presence and absence of Science Direct journals (subject category “pharmacology, toxicology and 
pharmaceutical science”) in JCR 
  No. of  Impact factor 
  journals
Particular top impact journal in 
Science Direct Scopus JCR 
Not included in the JCR 10 NeuroRX 2.261 - 
Included in JCR:     
 Subject pharmacology and pharmacy 40 Trends in Pharmacological 
Sciences 
10.504 10.372 
 Subject toxicology 10 Critical Reviews in Toxicology 5.233 5.000 
 Other subject categories 21 Pain 5.129 4.309 
Total no. of Science Direct journals 81    
 
 
As can be seen in Table 6, 10 out of 81 titles were not covered by JCR in the year 2005. For each of these 
journals, we computed a relatively low impact factor. Only one Science Direct journal (“NeuroRX”), with an 
impact factor amounting to 2.261, would place in the JCR top 100 ranking. For four titles (“Acute Pain”, “The 
American Journal of Geriatric Pharmacotherapy”, “Journal of Clinical Forensic Medicine” and “Legal Medicine”) 
an impact factor was calculated which would rank these journals better than the worst ranked (193rd) JCR pharma 
journal. The impact factor of the other five journals could not be computed because of publication or indexing 
irregularities. 
From the remaining 71 journals, 40 were covered under the subject categories “pharmacology and pharmacy”, 
10 under “toxicology” and 21 under other categories such as “medicine” in JCR. 31 of the 40 titles were among 
the JCR top 100 pharma journals, i.e. almost one third of the JCR top 100 pharmaceutical journals are currently 
published by Elsevier and are available in full text via Science Direct. Four of these journals are in the top 10, 
with “Trends in Pharmacological Sciences” ranked best in fifth position. Comparing the impact factors between 
Scopus and JCR revealed again that most journals have a higher value for this indicator in the Scopus database. 
Also the distribution of the differences (in percent) is similar. 
In order to determine further “candidates” for important journals, we tied up to the results of a study by 
Schloegl and Gorraiz [18] which showed a low to moderate correlation between the journal requests at a 
document delivery service and the citation frequencies of those journals in the JCR. Accordingly, we used data 
from Subito [19], one of the largest European document delivery services, and examined highly demanded 
journals for inclusion in JCR and Scopus. Our comparison revealed that from the top 100 JCR journals (subject 
category “pharmacology and pharmacy”) 60 titles were among the 1000 most requested journals in Subito. 
Furthermore, we identified three Subito journals (“Current Pharmaceutical Biotechnology”, “Pediatric Drugs”, 
and “Expert Opinion on Drug Safety”) which were included in Scopus but not in JCR. The computed impact 
factors in Scopus amounted to 2.578, 2.188 and 1.798. This would place them 59th, 78th and 103rd in the JCR 
ranking. 
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4. Conclusions  
The most relevant implications of our study can be resumed as follows: 
Coverage: 
Our analysis showed that both WOS and Scopus have a good coverage of high impact journals in the field of 
pharmacology and pharmacy. We could identify a few pharmaceutical journals with a significant but not top 
impact factor which were not included in the JCR. We computed higher values for both impact factor and 
immediacy index for most journals in Scopus. This is mainly due to the fact that there are more sources in Scopus 
which generate higher citations in this database and confirms that Scopus is the world's largest multidisciplinary 
database in terms of more recent scholarly literature (the back files of the Web of Science go back much further to 
the past). 
Subject categories: 
The subject categorisation is not very extensive in either database. Furthermore, the assignment of subject 
categories to journals is not always transparent and differs between Scopus and WOS. This can lead to more or 
less considerable differences when comparing the two databases. Obviously, a more detailed subject 
categorisation and a better journal classification would improve the quality of the two databases. 
Document types: 
Another implication of our study is that Scopus and the Web of Science provide different document types and 
that they do not assign them always consistently. As our analysis has shown, a different assignment to document 
types was one of the main reasons for mismatches in the number of (research) articles.  
Reliability of data: 
The differences in the number of research and review articles were tolerable for the majority of the 
investigated journals. Nevertheless, we calculated greater differences for several journals which were caused by 
both Scopus and WOS. Furthermore, data consistency between WOS and JCR cannot be taken for granted. In 
cases where data accuracy is crucial, it is advisable to verify the data. 
Appropriateness for bibliometric analyses: 
In our study, Scopus turned out to be suitable for bibliometric analyses. However, the practicability of such 
studies could be much increased if Scopus were to add an own bibliometric “infrastructure” comparable to the 
Journal Citation Reports to its citation database. Since such an add-on could be implemented from scratch, critical 
issues concerning the JCR could be avoided from the beginning. Among other issues [see e.g. 20], this applies to 
field-normalized journal impact indicators [e.g. 21, p. 1993f.]. Furthermore, it could be avoided to mix different 
document types when relating the citation frequencies to the article counts [e.g. 22,23]. Concerning conference 
articles, Scopus is more transparent than the Web of Knowledge. For the latter it is not always clear in which 
cases proceedings, which are recorded in ISI Proceedings in general, are included. 
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